| Dr Brian Thomas Jubeck, MD | |
|
1008 Beloit Ct, Madison, WI 53705-2233 | |
| (608) 957-5400 | |
| Not Available |
| Full Name | Dr Brian Thomas Jubeck |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 17 Years |
| Location | 1008 Beloit Ct, Madison, Wisconsin |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285852889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 52786 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waukesha Memorial Hospital | Waukesha, WI | Hospital |
| Oconomowoc Memorial Hospital | Oconomowoc, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Apogee Medical Group Waukesha Sc | 1153670054 | 40 |
News Archive
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that adoption of the company's Patient Access Intelligence (PAI) solution by hospitals around the country has been robust since its introduction earlier this year and continues to grow, according to Mike Gallagher, chief executive officer of MedeAnalytics. Orlando Health, Saint Vincent Catholic Medical Centers in New York, University of Maryland Medical System (UMMS), and Wheaton Franciscan Healthcare have adopted PAI, officially launched in 2009 at HFMA's Fall Revenue Cycle Strategies Conference in Chicago.
A new Finnish study shows that individual circadian preference is associated with brain activity patterns during the night.
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.
› Verified 8 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that adoption of the company's Patient Access Intelligence (PAI) solution by hospitals around the country has been robust since its introduction earlier this year and continues to grow, according to Mike Gallagher, chief executive officer of MedeAnalytics. Orlando Health, Saint Vincent Catholic Medical Centers in New York, University of Maryland Medical System (UMMS), and Wheaton Franciscan Healthcare have adopted PAI, officially launched in 2009 at HFMA's Fall Revenue Cycle Strategies Conference in Chicago.
A new Finnish study shows that individual circadian preference is associated with brain activity patterns during the night.
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.
› Verified 8 days ago
| Entity Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that adoption of the company's Patient Access Intelligence (PAI) solution by hospitals around the country has been robust since its introduction earlier this year and continues to grow, according to Mike Gallagher, chief executive officer of MedeAnalytics. Orlando Health, Saint Vincent Catholic Medical Centers in New York, University of Maryland Medical System (UMMS), and Wheaton Franciscan Healthcare have adopted PAI, officially launched in 2009 at HFMA's Fall Revenue Cycle Strategies Conference in Chicago.
A new Finnish study shows that individual circadian preference is associated with brain activity patterns during the night.
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.
› Verified 8 days ago
| Entity Name | Apogee Medical Group Waukesha Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528544608 PECOS PAC ID: 1153670054 Enrollment ID: O20180827002216 |
News Archive
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that adoption of the company's Patient Access Intelligence (PAI) solution by hospitals around the country has been robust since its introduction earlier this year and continues to grow, according to Mike Gallagher, chief executive officer of MedeAnalytics. Orlando Health, Saint Vincent Catholic Medical Centers in New York, University of Maryland Medical System (UMMS), and Wheaton Franciscan Healthcare have adopted PAI, officially launched in 2009 at HFMA's Fall Revenue Cycle Strategies Conference in Chicago.
A new Finnish study shows that individual circadian preference is associated with brain activity patterns during the night.
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Thomas Jubeck, MD 1008 Beloit Ct, Madison, WI 53705-2233 Ph: () - | Dr Brian Thomas Jubeck, MD 1008 Beloit Ct, Madison, WI 53705-2233 Ph: (608) 957-5400 |
News Archive
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that adoption of the company's Patient Access Intelligence (PAI) solution by hospitals around the country has been robust since its introduction earlier this year and continues to grow, according to Mike Gallagher, chief executive officer of MedeAnalytics. Orlando Health, Saint Vincent Catholic Medical Centers in New York, University of Maryland Medical System (UMMS), and Wheaton Franciscan Healthcare have adopted PAI, officially launched in 2009 at HFMA's Fall Revenue Cycle Strategies Conference in Chicago.
A new Finnish study shows that individual circadian preference is associated with brain activity patterns during the night.
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.
› Verified 8 days ago
Istiaq H Mian, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 | |
Dr. Jonathan Eric Fliegel, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-265-5545 Fax: 608-265-8074 | |
Edward Dunbar, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Tracy M. Reittinger, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-258-6100 Fax: 608-258-6259 | |
Bradley J Schmidt, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-258-6259 | |
Tin Nwe Oo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Alexander Kendziorski, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, St Marys Hospital Dean Medical Center, Madison, WI 53715 Phone: 608-251-6100 |